Design of a Phase 3 Randomized, Double-blinded, Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneous Efgartigimod PH20 Administered by Prefilled Syringe in Adults with Ocular Myasthenia Gravis (P1-11.003)
Year: 2025
Type: article
Study design: Study Protocol
Source: Neurology
Authors: Carolina Barnett-Tapia, James F. Howard, Jeff Guptill, Rosa Jimenez, Fien Gistelinck, Sophie Steeland, Fien Verhamme, Sui H. Wong
Institutions: University of Toronto, Argenx (Belgium), Moorfields Eye Hospital
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409237754